Personalized therapy for urothelial cancer: review of the clinical evidence.

about

Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.

P2860

Q35752069-B67EAC00-98AD-4BD8-9CE0-38D8DACC5282

P2860

Personalized therapy for urothelial cancer: review of the clinical evidence.

Item

http://www.wikidata.org/entity/Q36062762

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Personalized therapy for urothelial cancer: review of the clinical evidence.

@ast

Personalized therapy for urothelial cancer: review of the clinical evidence.

@en

type

Item

label

Personalized therapy for urothelial cancer: review of the clinical evidence.

@ast

Personalized therapy for urothelial cancer: review of the clinical evidence.

@en

prefLabel

Personalized therapy for urothelial cancer: review of the clinical evidence.

@ast

Personalized therapy for urothelial cancer: review of the clinical evidence.

@en

P1476

Personalized therapy for urothelial cancer: review of the clinical evidence.

@en

P2093

Dipanjan Chowdhury

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Guancial

http://www.w3.org/2001/XMLSchema#string

Jonathan E Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

The Hallmarks of Cancer

Cixutumumab

MicroRNAs: target recognition and regulatory functions

Susceptibility pathways in Fanconi's anemia and breast cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cancer statistics, 2010

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

P304

546-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/CLI.11.26

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228106428

http://www.w3.org/2001/XMLSchema#string

P698

22754656

http://www.w3.org/2001/XMLSchema#string

P932

3384687

http://www.w3.org/2001/XMLSchema#string

Personalized therapy for urothelial cancer: review of the clinical evidence.

about

P2860

P2860

Personalized therapy for urothelial cancer: review of the clinical evidence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932